Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kenkay is an Australian pharmaceutical company specializing in the development and distribution of therapeutic skincare products. The company is primarily known for its dermatological range designed to treat sensitive skin conditions such as eczema, dermatitis, and psoriasis. Its core product line includes sorbolene-based moisturizers, soap-free cleansers, and specialized relief creams that are widely available in the Australian pharmacy market. In 2011, Kenkay was acquired by Ego Pharmaceuticals, a leader in the Australian skincare industry, which integrated Kenkay's offerings into its broader portfolio. The brand continues to focus on high-quality, fragrance-free formulations that support skin barrier function and hydration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kenkay.